Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry

NCT05880537 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-04-02

No results posted yet for this study

Summary

Post market registry to assess the safety and efficacy of a novel decellularized human femoral artery allograft (Nexeon AVX Decellularized Femoral Artery,

Conditions

  • End-Stage Renal Disease

Interventions

OTHER

Nexeon Arterial Venous Allograft

Nexeon AVX allograft for hemodialysis access in end stage renal disease

Sponsors & Collaborators

  • LifeNet Health

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-06
Primary Completion
2027-12-15
Completion
2027-12-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05880537 on ClinicalTrials.gov